Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy

被引:1127
|
作者
Delettre, C
Lenaers, G
Griffoin, JM
Gigarel, N
Lorenzo, C
Belenguer, P
Pelloquin, L
Grosgeorge, J
Turc-Carel, C
Perret, E
Astarie-Dequeker, C
Lasquellec, L
Arnaud, B
Ducommun, B
Kaplan, J
Hamel, CP [1 ]
机构
[1] INSERM, U254, Lab Neurobiol Audit, Montpellier, France
[2] Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088, F-31062 Toulouse, France
[3] Hop Necker Enfants Malad, INSERM, U393, Paris, France
[4] Fac Med, CNRS, UNSA, UMR 6549, Nice, France
[5] Sanofi Synthelabo, Labege, France
[6] Inst Pharmacol & Biol Struct, CNRS, UPR 9062, Toulouse, France
[7] Hop Gui Chauliac, Serv Ophthalmol, Montpellier, France
关键词
D O I
10.1038/79936
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Optic: atrophy type 1 (OPA1. MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50.000 individuals(1-3) that features progressive loss in visual acuity leading, in many cases, to legal blindness(4-8). Phenotypic variations(5) and loss of retinal ganglion cells(9,10), as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment(11,12). The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [41] Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy
    Kane, Mariame Selma
    Alban, Jennifer
    Desquiret-Dumas, Valerie
    Gueguen, Naig
    Ishak, Layal
    Ferre, Marc
    Amati-Bonneau, Patrizia
    Procaccio, Vincent
    Bonneau, Dominique
    Lenaers, Guy
    Reynier, Pascal
    Chevrollier, Arnaud
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (10) : 2284 - 2297
  • [42] Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy
    Toomes, C
    Marchbank, NJ
    Mackey, DA
    Craig, JE
    Newbury-Ecob, RA
    Bennett, CP
    Vize, CJ
    Desai, SP
    Black, GCM
    Patel, N
    Teimory, M
    Markham, AF
    Inglehearn, CF
    Churchill, AJ
    HUMAN MOLECULAR GENETICS, 2001, 10 (13) : 1369 - 1378
  • [43] Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease
    Marchbank, N. J.
    Craig, J. E.
    Leek, J. P.
    Toohey, M.
    Churchill, A. J.
    Markham, A. F.
    Mackey, D. A.
    Toomes, C.
    Inglehearn, C. F.
    JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : e47
  • [44] First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report
    Weisschuh, Nicole
    Mazzola, Pascale
    Heinrich, Tilman
    Haack, Tobias
    Wissinger, Bernd
    Tonagel, Felix
    Kelbsch, Carina
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [45] Dominant optic atrophy caused by a novel OPA1 mutation:: Disruption of the mitochondrial network with preserved bioenergetics
    Spinazzi, Marco
    Cazzola, Silvia
    Bortolozzi, Mario
    Baracca, Alessandra
    Loro, Emanuele
    Solaini, Giancarlo
    Sgarbi, Gianluca
    Cenacchi, Giovanna
    Malena, Adriana
    Scorrano, Luca
    Frezza, Christian
    Angelini, Corrado
    Vergani, Lodovica
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 : S56 - S56
  • [46] Novel OPA1 mutation in syndromic mitochondrial dominant optic atrophy (DOA plus ): a case report
    Thavapalan, V.
    Liang, T. -W.
    Rakocevic, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 719 - 719
  • [47] Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy
    Fuhrmann, N.
    Alavi, M. V.
    Bitoun, P.
    Woernle, S.
    Auburger, G.
    Leo-Kottler, B.
    Yu-Wai-Man, P.
    Chinnery, P.
    Wissinger, B.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 (02) : 136 - 144
  • [48] Dominant optic atrophy family with a microdeletion at 3q28 encompassing the OPA1 gene: Evidence that haploinsufficiency of OPA1 is the cause of disease
    Marchbank, NJ
    Leek, JP
    Craig, JE
    Toohey, M
    Churchill, AJ
    Mackey, DA
    Markham, AF
    Toomes, C
    Inglehearn, CF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U174 - U174
  • [49] A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
    Mei, Shaoyi
    Huang, Xiaosheng
    Cheng, Lin
    Peng, Shiming
    Zhu, Tianhui
    Chen, Liang
    Wang, Yan
    Zhao, Jun
    JOURNAL OF OPHTHALMOLOGY, 2019, 2019
  • [50] Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1)
    Brown, J
    Fingert, JH
    Taylor, CM
    Lake, M
    Sheffield, VC
    Stone, EM
    ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (01) : 95 - 99